Acadia Healthcare falls after Raymond James downgrade
ACHC•Acadia Healthcare shares fell 1.6% after Raymond James downgraded the stock to “outperform” from “strong buy.” The firm kept its price target at $39; the median brokerage target was $32.50.
1. Rating change
Raymond James said Acadia’s long-term fundamentals remain intact, but limited near-term visibility makes it difficult for the stock to receive full credit for its potential improvement. Eight of 14 brokerages rated the stock “buy” or higher, five rated it “hold” and one rated it “sell.”
